Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000096754

Apexbio Technology LLC Lapatinib Ditosylate 388082-77-7 50mg
SDP

Catalog No. 5000096754
Encompass_Preferred

Lapatinib Ditosylate (CAS 388082-77-7) is a reversible dual inhibitor of the ErbB-2 (HER2) and epidermal growth factor receptor (EGFR) tyrosine kinases It competitively binds to the ATP-binding sites of these receptors preventing activation and downstream signaling In vitro Lapatinib Ditosylate exhibits potent inhibition with IC50 values of 9 2 nM for ErbB-2 and 10 8 nM for EGFR and demonstrates over 300-fold selectivity compared to kinases such as MEK and ERK The compound suppresses proliferation and downstream phosphorylation events (Erk1/2 AKT) in cancer cell lines overexpressing ErbB-2/EGFR and induces G1 cell cycle arrest In vivo it reduces tumor growth in xenograft mouse models Lapatinib Ditosylate is widely utilized in studies exploring receptor tyrosine kinase function and targeted cancer therapies

Catalog No. 50-000-96754 Supplier Apexbio Technology LLC Supplier No. A396750
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lapatinib Ditosylate (CAS 388082-77-7) is a reversible dual inhibitor of the ErbB-2 (HER2) and epidermal growth factor receptor (EGFR) tyrosine kinases It competitively binds to the ATP-binding sites of these receptors preventing activation and downstream signaling In vitro Lapatinib Ditosylate exhibits potent inhibition with IC50 values of 9 2 nM for ErbB-2 and 10 8 nM for EGFR and demonstrates over 300-fold selectivity compared to kinases such as MEK and ERK The compound suppresses proliferation and downstream phosphorylation events (Erk1/2 AKT) in cancer cell lines overexpressing ErbB-2/EGFR and induces G1 cell cycle arrest In vivo it reduces tumor growth in xenograft mouse models Lapatinib Ditosylate is widely utilized in studies exploring receptor tyrosine kinase function and targeted cancer therapies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.